Suchergebnisse - "Xiao, Jun"

PubPharm (87)

1

Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial) : A randomized controlled trial

enthalten in: PLoS medicine | 2024

von Wang, D. | Ren, C. | Li, S. | +29

2

Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD : a multicentre, randomized trial

enthalten in: BMC medicine | 2024

von Wang, Y. | Liu, Q. | Wu, D. | +14

3

Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT) : Initial Results of a Phase III Trial

enthalten in: Annals of surgery | 2023

von Mei, W. | Wang, X. | Li, Y. | +36

4

Personalized smart voice-based electronic prescription for remote at-home feedback management in cardiovascular disease rehabilitation : a multi-center randomized controlled trial

enthalten in: Frontiers in public health | 2023

von Zhu, Y. | Xia, L. | Yan, J. | +8

5

Machine learning algorithm as a prognostic tool for venous thromboembolism in allogeneic transplant patients

enthalten in: Transplantation and cellular therapy | 2023

von Deng, R. | Zhu, X. | Zhang, A. | +18

6

Consequences of Preoperative Oral Carbohydrate Consumption in Septal Deviation Patients Undergoing Endoscopic Septoplasty : A Retrospective Cohort Study

enthalten in: Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses | 2022

von Zhu, J. | Sun, L. | Liu, Y. | +5

7

Relation of Carotid Plaque Features Detected with Ultrasonography-Based Radiomics to Clinical Symptoms

enthalten in: Translational stroke research | 2022

von Huang, Z. | Cheng, X. | Liu, H. | +5

CommentIn: Transl Stroke Res. 2022 Aug;13(4):505-506. - PMID 35028923

8

Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART) : a randomised, open-label, phase 3 trial

enthalten in: The Lancet. Oncology | 2022

von Gu, W. | Han, W. | Luo, H. | +24

CommentIn: Lancet Oncol. 2022 Oct;23(10):1234-1235. - PMID 36075259

9

Predictive scoring systems for molecular responses in persons with chronic phase chronic myeloid leukemia receiving initial imatinib therapy

enthalten in: Leukemia | 2022

von Zhang, X. | Gale, R. | Li, Z. | +3

10

A predictive scoring system for therapy-failure in persons with chronic myeloid leukemia receiving initial imatinib therapy

enthalten in: Leukemia | 2022

von Zhang, X. | Gale, R. | Zhang, M. | +2

1
2
3
4
5
6
7
8
9
Nächster »
[9]